Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00221104
Status:
COMPLETED
Last Update Posted:
2018-01-25
First Post:
2005-09-13
Brief Title:
Japan Statin Treatment Against Recurrent Stroke J-STARS
Sponsor:
Translational Research Center for Medical Innovation Kobe Hyogo Japan
Organization:
Translational Research Center for Medical Innovation Kobe Hyogo Japan
Study Overview
Official Title:
Secondary Prevention With HMG-CoA Reductase Inhibitor Against Stroke
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Although hyperlipidemia is not always the risk factor of stroke inhibition of 3-hydroxy-3-methylglutaryl-coenzyme AHMG-CoA reductase can decrease the incidence of stroke in the patient with ischemic heart disease The neuroprotective mechanism beyond cholesterol lowering should be expected to attenuate inflammation and atherosclerosis The present study hypothesizes if pravastatin prevents recurrent stroke in the ischemic stroke patients with safety
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| C000000207 | OTHER | UMIN CTR | None |